tradingkey.logo
๎™ผ
tradingkey.logo
๎™๊ฒ€์ƒ‰
๎™

Sinovac Biotech Ltd

SVA
๎˜ญ๊ด€์‹ฌ ๋ชฉ๋ก์— ์ถ”๊ฐ€
0.000USD
0.0000.00%
์ข…๊ฐ€ย 12-22 16:00๏ผˆET๏ผ‰
0.00์‹œ๊ฐ€์ด์•ก
0.00P/E TTM

Sinovac Biotech Ltd ์ •๋ณด ํšŒ์‚ฌ

Sinovac Biotech Ltd (Sinovac) is a holding company. The Company is a biopharmaceutical company that focuses on the research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases, including hepatitis A, hepatitis B, hand foot and mouth disease (HFMD), seasonal influenza, Haemagglutinase5 Neuraminidase1 (H5N1) and Influenza A (H1N1) pandemic influenza, coronavirus, pneumococcus, poliomyelitis, varicella and mumps. The Company's pipeline consists of vaccine candidates in the clinical and pre-clinical development Phases in China. The Company is engaged in the sales, marketing, manufacturing and development of vaccines for infectious disease. The Company develops various products, including Healive, Bilive, Anflu, Panflu Whole Viron Pandemic Influenza Vaccine, Split Viron Pandemic Influenza Vaccine, Panflu.1, Mumps Vaccine, Enterovirus 71 (EV71) Vaccine, Pneumococcal Polysaccharide Vaccine, Pneumococcal Conjugate Vaccine.

Sinovac Biotech Ltd ํ”„๋กœํ•„

๎™Œ
์ข…๋ชฉ ์ฝ”๋“œ SVA
ํšŒ์‚ฌ ์ด๋ฆ„Sinovac Biotech Ltd
์ƒ์žฅ์ผNov 13, 2009
CEOYin (Weidong)
์ง์› ์ˆ˜3037
์œ ํ˜•Ordinary Share
ํšŒ๊ณ„ ์—ฐ๋„ ์ข…๋ฃŒNov 13
์ฃผ์†ŒNo. 39 Shangdi Xi Road
๋„์‹œBEIJING
์ฆ๊ถŒ ๊ฑฐ๋ž˜์†ŒNASDAQ OMX - NASDAQ BASIC
๊ตญ๊ฐ€China
์šฐํŽธ ๋ฒˆํ˜ธ100085
์ „ํ™”861082890088
์›น์‚ฌ์ดํŠธhttp://www.sinovac.com/
์ข…๋ชฉ ์ฝ”๋“œ SVA
์ƒ์žฅ์ผNov 13, 2009
CEOYin (Weidong)

Sinovac Biotech Ltd์˜ ํšŒ์‚ฌ ์ž„์›์ง„

๎™Œ
์ด๋ฆ„
์ด๋ฆ„/์ง์œ„
์ง์œ„
์ฃผ์‹ ๋ณด์œ 
๋ณ€๋™
Dr. Chiang Li
Dr. Chiang Li
Independent Director
Independent Director
18.52M
--
Mr. Weidong Yin
Mr. Weidong Yin
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
6.36M
--
Mr. Simon J. Anderson
Mr. Simon J. Anderson
Independent Director
Independent Director
--
--
Prof. Lam Lo Yuk
Prof. Lam Lo Yuk
Independent Director
Independent Director
--
--
Ms. Wang Nan
Ms. Wang Nan
Chief Financial Officer, Vice President
Chief Financial Officer, Vice President
--
--
Mr. Fu Shan
Mr. Fu Shan
Independent Director
Independent Director
--
--
Mr. Gao Qiang
Mr. Gao Qiang
Chief Operating Officer, Vice President
Chief Operating Officer, Vice President
--
--
Ms. Li Jing
Ms. Li Jing
Vice President - Quality and Production
Vice President - Quality and Production
--
--
Ms. Yang (Helen) Guang
Ms. Yang (Helen) Guang
Chief Business Officer
Chief Business Officer
--
--
Mr. Jiao Shuge
Mr. Jiao Shuge
Independent Director
Independent Director
--
--
๋” ๋ณด๊ธฐ
์ด๋ฆ„
์ด๋ฆ„/์ง์œ„
์ง์œ„
์ฃผ์‹ ๋ณด์œ 
๋ณ€๋™
Dr. Chiang Li
Dr. Chiang Li
Independent Director
Independent Director
18.52M
--
Mr. Weidong Yin
Mr. Weidong Yin
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
6.36M
--
Mr. Simon J. Anderson
Mr. Simon J. Anderson
Independent Director
Independent Director
--
--
Prof. Lam Lo Yuk
Prof. Lam Lo Yuk
Independent Director
Independent Director
--
--
Ms. Wang Nan
Ms. Wang Nan
Chief Financial Officer, Vice President
Chief Financial Officer, Vice President
--
--
Mr. Fu Shan
Mr. Fu Shan
Independent Director
Independent Director
--
--

์ž์ฃผ ๋ฌป๋Š” ์งˆ๋ฌธ

Sinovac Biotech Ltd์˜ ์ƒ์œ„ 5๋Œ€ ์ฃผ์ฃผ๋Š” ๋ˆ„๊ตฌ์ธ๊ฐ€์š”?

๎™Œ
Sinovac Biotech Ltd์˜ ์ƒ์œ„ 5๋Œ€ ์ฃผ์ฃผ๋Š” ๋‹ค์Œ๊ณผ ๊ฐ™์Šต๋‹ˆ๋‹ค: Dr. Chiang Li

Sinovac Biotech Ltd(SVA)์˜ ์ฃผ์‹์„ ๋ณด์œ ํ•œ ๊ธฐ๊ด€์€ ๋ช‡ ๊ฐœ์ž…๋‹ˆ๊นŒ?

๎™Œ
2026Q1 ๊ธฐ์ค€์œผ๋กœ, Sinovac Biotech Ltd์˜ ์ฃผ์‹์„ ๋ณด์œ ํ•œ ๊ธฐ๊ด€์€ ์ด 42๊ณณ์ด๋ฉฐ, ์ด๋“ค์ด ๋ณด์œ ํ•œ ์ฃผ์‹์˜ ์ด ๊ฐ€์น˜๋Š” ์•ฝ 21.25M๋กœ ์ „์ฒด ๋ฐœํ–‰ ์ฃผ์‹์˜ 35.39%๋ฅผ ์ฐจ์ง€ํ•ฉ๋‹ˆ๋‹ค. ์ด๋Š” 2025Q4 ๋Œ€๋น„ -256496.00 ์ฆ๊ฐ€ํ•œ ์ˆ˜์น˜์ž…๋‹ˆ๋‹ค.
tradingkey.logo
์œ„ํ—˜ ๊ฒฝ๊ณ : ์ €ํฌ ์›น์‚ฌ์ดํŠธ์™€ ๋ชจ๋ฐ”์ผ ์•ฑ์€ ํŠน์ • ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ผ๋ฐ˜์ ์ธ ์ •๋ณด๋งŒ์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. Finsights๋Š” ์žฌ์ •์  ์กฐ์–ธ์ด๋‚˜ ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜์ง€ ์•Š์œผ๋ฉฐ, ์ด๋Ÿฌํ•œ ์ •๋ณด ์ œ๊ณต์ด Finsights๊ฐ€ ๊ธˆ์œต ์กฐ์–ธ์ด๋‚˜ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜๋Š” ๊ฒƒ์œผ๋กœ ํ•ด์„๋˜์–ด์„œ๋Š” ์•ˆ ๋ฉ๋‹ˆ๋‹ค.
ํˆฌ์ž ์ƒํ’ˆ์€ ํˆฌ์ž ์›๊ธˆ ์†์‹ค์„ ํฌํ•จํ•œ ์ƒ๋‹นํ•œ ํˆฌ์ž ์œ„ํ—˜์— ๋…ธ์ถœ๋˜์–ด ์žˆ์œผ๋ฉฐ, ๋ชจ๋“  ์‚ฌ๋žŒ์—๊ฒŒ ์ ํ•ฉํ•˜์ง€ ์•Š์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค. ํˆฌ์ž ์ƒํ’ˆ์˜ ๊ณผ๊ฑฐ ์„ฑ๊ณผ๋Š” ๋ฏธ๋ž˜ ์„ฑ๊ณผ๋ฅผ ๋ณด์žฅํ•˜์ง€ ์•Š์Šต๋‹ˆ๋‹ค.
Finsights๋Š” ์ œ3์ž ๊ด‘๊ณ ์ฃผ๋‚˜ ์ œํœด์‚ฌ๊ฐ€ ์ €ํฌ ์›น์‚ฌ์ดํŠธ๋‚˜ ๋ชจ๋ฐ”์ผ ์•ฑ ๋˜๋Š” ๊ทธ ์ผ๋ถ€์— ๊ด‘๊ณ ๋ฅผ ๊ฒŒ์žฌํ•˜๊ฑฐ๋‚˜ ์ „๋‹ฌํ•  ์ˆ˜ ์žˆ๋„๋ก ํ—ˆ์šฉํ•  ์ˆ˜ ์žˆ์œผ๋ฉฐ, ์‚ฌ์šฉ์ž๊ฐ€ ๊ด‘๊ณ ์™€ ์ƒํ˜ธ์ž‘์šฉํ•˜๋Š” ๋ฐฉ์‹์— ๋”ฐ๋ผ ์ด๋“ค๋กœ๋ถ€ํ„ฐ ๋ณด์ƒ์„ ๋ฐ›์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.
ยฉ ์ €์ž‘๊ถŒ: FINSIGHTS MEDIA PTE. LTD. ๋ชจ๋“  ๊ถŒ๋ฆฌ ๋ณด์œ